PT3351630T - Composição farmacêutica compreendendo anticorpos anti caprin-1 para tratar e/ou prevenir o cancro - Google Patents
Composição farmacêutica compreendendo anticorpos anti caprin-1 para tratar e/ou prevenir o cancroInfo
- Publication number
- PT3351630T PT3351630T PT171636905T PT17163690T PT3351630T PT 3351630 T PT3351630 T PT 3351630T PT 171636905 T PT171636905 T PT 171636905T PT 17163690 T PT17163690 T PT 17163690T PT 3351630 T PT3351630 T PT 3351630T
- Authority
- PT
- Portugal
- Prior art keywords
- antibodies
- treating
- pharmaceutical composition
- preventing cancer
- anti caprin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011171300 | 2011-08-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3351630T true PT3351630T (pt) | 2019-12-30 |
Family
ID=47629408
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT171636905T PT3351630T (pt) | 2011-08-04 | 2012-08-03 | Composição farmacêutica compreendendo anticorpos anti caprin-1 para tratar e/ou prevenir o cancro |
| PT128205960T PT2740796T (pt) | 2011-08-04 | 2012-08-03 | Composição farmacêutica para o tratamento e/ou profilaxia de cancro |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT128205960T PT2740796T (pt) | 2011-08-04 | 2012-08-03 | Composição farmacêutica para o tratamento e/ou profilaxia de cancro |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9273128B2 (pt) |
| EP (2) | EP3351630B1 (pt) |
| JP (1) | JP6070191B2 (pt) |
| KR (1) | KR101979208B1 (pt) |
| CN (1) | CN103717740B (pt) |
| AU (1) | AU2012290957B2 (pt) |
| BR (1) | BR112014002608A2 (pt) |
| CA (1) | CA2844042C (pt) |
| DK (2) | DK3351630T3 (pt) |
| ES (2) | ES2634249T3 (pt) |
| HU (2) | HUE047006T2 (pt) |
| MX (1) | MX351682B (pt) |
| PL (2) | PL2740796T3 (pt) |
| PT (2) | PT3351630T (pt) |
| RU (1) | RU2641260C2 (pt) |
| WO (1) | WO2013018894A1 (pt) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102170907A (zh) | 2008-08-05 | 2011-08-31 | 东丽株式会社 | 用于治疗和预防癌症的药物组合物 |
| WO2010016527A1 (ja) | 2008-08-05 | 2010-02-11 | 東レ株式会社 | 癌の検出方法 |
| RU2607366C2 (ru) | 2010-02-04 | 2017-01-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| CA2788716C (en) | 2010-02-04 | 2019-06-18 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| WO2011096519A1 (ja) | 2010-02-04 | 2011-08-11 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| US8911740B2 (en) | 2010-02-04 | 2014-12-16 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| KR101805520B1 (ko) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| ES2691738T3 (es) | 2010-02-04 | 2018-11-28 | Toray Industries, Inc. | Agente farmacéutico para el tratamiento y/o la prevención de cáncer |
| RU2630638C2 (ru) * | 2011-08-04 | 2017-09-11 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака поджелудочной железы |
| MX349907B (es) | 2011-08-04 | 2017-08-18 | Toray Industries | Metodo para detectar cancer pancreatico. |
| HUE047006T2 (hu) | 2011-08-04 | 2020-04-28 | Toray Industries | Anti-caprin-1 antitesteket tartalmazó gyógyászati kompozíció rák kezelésére és/vagy megelõzésére |
| CA2844034C (en) | 2011-08-04 | 2019-07-16 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| KR101968499B1 (ko) | 2011-08-04 | 2019-04-12 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| HUE035689T2 (en) | 2011-08-04 | 2018-05-28 | Toray Industries | A pharmaceutical composition for the treatment and / or prevention of cancer |
| JP6065590B2 (ja) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| IN2014KN01713A (pt) | 2012-02-21 | 2015-10-23 | Toray Industries | |
| KR102005308B1 (ko) | 2012-02-21 | 2019-07-30 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| ES2739380T3 (es) | 2012-02-21 | 2020-01-30 | Toray Industries | Composición farmacéutica para el tratamiento del cáncer |
| PT2818483T (pt) | 2012-02-21 | 2017-10-09 | Toray Industries | Composição medicinal para tratamento e/ou prevenção de cancro |
| CN104203281B (zh) | 2012-03-30 | 2019-07-26 | 东丽株式会社 | 胆囊癌的治疗和/或预防用药物组合物 |
| CA2869120C (en) | 2012-03-30 | 2023-05-23 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
| DK2876446T3 (en) | 2012-07-19 | 2019-03-11 | Toray Industries | Method for detecting cancer |
| DK2876447T3 (da) | 2012-07-19 | 2020-02-24 | Toray Industries | Fremgangsmåde til detektering af cancer |
| RU2678138C2 (ru) | 2013-08-09 | 2019-01-23 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| CN108779497B (zh) * | 2016-03-14 | 2022-08-02 | 库雷梅塔治疗有限责任公司 | 足糖萼蛋白和tra-相关抗体、制备方法和作为抗癌治疗剂的用途 |
| KR102590454B1 (ko) | 2016-07-07 | 2023-10-17 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
| US20200054762A1 (en) | 2016-10-28 | 2020-02-20 | Toray Industries, Inc. | Pharmaceutical composition for cancer treatment and/or prevention |
| WO2018164019A1 (en) * | 2017-03-04 | 2018-09-13 | Kyoto University | Therapeutic peptides |
| AU2019242520A1 (en) | 2018-03-30 | 2020-10-29 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
| EP3937984A1 (en) | 2019-03-15 | 2022-01-19 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| JPWO2021182571A1 (pt) | 2020-03-12 | 2021-09-16 | ||
| KR20220153621A (ko) | 2020-03-12 | 2022-11-18 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| JPWO2021182573A1 (pt) | 2020-03-12 | 2021-09-16 | ||
| WO2021182572A1 (ja) | 2020-03-12 | 2021-09-16 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| BR112022018161A2 (pt) | 2020-03-12 | 2022-10-25 | Toray Industries | Medicamento para o tratamento e/ou prevenção do câncer, agentes que aumentam a eficácia de um fármaco e método para o tratamento e/ou prevenção do câncer |
| KR20240024074A (ko) | 2021-06-23 | 2024-02-23 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
| WO2022270524A1 (ja) | 2021-06-23 | 2022-12-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| CN117677398A (zh) | 2021-07-27 | 2024-03-08 | 东丽株式会社 | 用于癌的治疗和/或预防的药品 |
| US20250066502A1 (en) | 2021-07-27 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| MX2024001099A (es) | 2021-07-27 | 2024-02-23 | Toray Industries | Medicamento para el tratamiento y/o prevencion de cancer. |
| CN118119409A (zh) | 2021-09-03 | 2024-05-31 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
| AU2023298568A1 (en) | 2022-06-30 | 2025-01-09 | Toray Industries, Inc. | Pharmaceutical composition for cancer treatment and/or prevention |
| AU2023329558A1 (en) | 2022-08-24 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| WO2024043258A1 (ja) | 2022-08-24 | 2024-02-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| WO2024043257A1 (ja) | 2022-08-24 | 2024-02-29 | 東レ株式会社 | 癌の治療及び／又は予防のための医薬品 |
| AU2023334696A1 (en) | 2022-08-30 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
| AU2023334695A1 (en) | 2022-08-30 | 2025-02-27 | Toray Industries, Inc. | Medicament for treatment and/or prevention of cancer |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698396A (en) | 1995-06-07 | 1997-12-16 | Ludwig Institute For Cancer Research | Method for identifying auto-immunoreactive substances from a subject |
| WO2001032910A2 (en) | 1999-10-29 | 2001-05-10 | Human Genome Sciences, Inc. | 27 human secreted proteins |
| US20030118599A1 (en) | 1999-04-02 | 2003-06-26 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| CN100419079C (zh) | 1998-07-14 | 2008-09-17 | 科里克萨有限公司 | 用于治疗和诊断前列腺癌的组合物和方法 |
| RU2234942C2 (ru) | 1998-07-14 | 2004-08-27 | Корикса Корпорейшн | Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид |
| US6969518B2 (en) | 1998-12-28 | 2005-11-29 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
| WO2000052204A2 (en) | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
| US6444425B1 (en) | 1999-04-02 | 2002-09-03 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
| JP2002540790A (ja) | 1999-04-02 | 2002-12-03 | コリクサ コーポレイション | 肺癌の治療および診断のための化合物ならびにその使用のための方法 |
| US6949245B1 (en) | 1999-06-25 | 2005-09-27 | Genentech, Inc. | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| US20020006404A1 (en) | 1999-11-08 | 2002-01-17 | Idec Pharmaceuticals Corporation | Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
| CZ20023567A3 (cs) | 2000-03-29 | 2003-11-12 | Corixa Corporation | Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic |
| US7919467B2 (en) | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US20040029114A1 (en) | 2001-01-24 | 2004-02-12 | Eos Technology, Inc. | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| RU2306952C2 (ru) | 2001-01-31 | 2007-09-27 | Байоджен Айдек Инк. | Лечение в-клеточных злокачественных опухолей с использованием комбинации применений, связанных с антителами, уменьшающими количество b-клеток, и с иммуномодулирующими антителами |
| AU2002311787A1 (en) | 2001-03-28 | 2002-10-15 | Zycos Inc. | Translational profiling |
| WO2002083070A2 (en) | 2001-04-10 | 2002-10-24 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| EP1516049A4 (en) | 2001-05-11 | 2006-01-11 | Corixa Corp | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF LUNG CANCER |
| US20030190640A1 (en) | 2001-05-31 | 2003-10-09 | Mary Faris | Genes expressed in prostate cancer |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| EP2388265A1 (en) | 2002-02-22 | 2011-11-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20050003390A1 (en) | 2002-05-17 | 2005-01-06 | Axenovich Sergey A. | Targets for controlling cellular growth and for diagnostic methods |
| US20040126379A1 (en) | 2002-08-21 | 2004-07-01 | Boehringer Ingelheim International Gmbh | Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents |
| CA2504144A1 (en) | 2002-11-26 | 2004-06-10 | Genentech, Inc. | Compositions and methods for the diagnosis of immune related diseases using pro7 |
| WO2004076682A2 (en) | 2003-02-26 | 2004-09-10 | Surromed, Inc. | Targets for controlling cellular growth and for diagnostic methods |
| CA2524173A1 (en) | 2003-04-29 | 2004-11-11 | Wyeth | Methods for diagnosing aml and mds differential gene expression |
| US20060019256A1 (en) | 2003-06-09 | 2006-01-26 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2005007830A2 (en) | 2003-07-14 | 2005-01-27 | Mayo Foundation For Medical Education And Research | Methods and compositions for diagnosis, staging and prognosis of prostate cancer |
| US20050032113A1 (en) | 2003-07-17 | 2005-02-10 | Mitsubishi Pharma Corporation | Membrane protein library for proteome analysis and method for preparing same |
| EP1711525A2 (en) | 2004-01-26 | 2006-10-18 | Debiovision Inc. | Neoplasm-specific polypeptides and their uses |
| EP1735348B1 (en) | 2004-03-19 | 2012-06-20 | Imclone LLC | Human anti-epidermal growth factor receptor antibody |
| WO2005100998A2 (en) | 2004-04-16 | 2005-10-27 | Europroteome Ag | Membrane markers for use in cancer diagnosis and therapy |
| WO2006002378A2 (en) | 2004-06-23 | 2006-01-05 | Avalon Pharmaceuticals | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| KR20150083139A (ko) | 2005-01-21 | 2015-07-16 | 제넨테크, 인크. | Ｈｅｒ 항체의 고정 용량 투여법 |
| CA2598217A1 (en) | 2005-02-18 | 2006-08-24 | Marsha A. Moses | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
| KR101310000B1 (ko) | 2005-03-11 | 2013-09-25 | 싸이퍼젠 바이오시스템즈, 인코포레이티드 | 난소암 및 자궁내막암에 대한 바이오마커 : 헵시딘 |
| JP2006316040A (ja) | 2005-05-13 | 2006-11-24 | Genentech Inc | Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法 |
| US8014957B2 (en) | 2005-12-15 | 2011-09-06 | Fred Hutchinson Cancer Research Center | Genes associated with progression and response in chronic myeloid leukemia and uses thereof |
| CA2642342A1 (en) | 2006-02-14 | 2007-08-23 | Dana-Farber Cancer Institute, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer |
| US20080131428A1 (en) * | 2006-02-24 | 2008-06-05 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| US20100015724A1 (en) | 2006-08-17 | 2010-01-21 | Peter Hornbeck | Lysine acetylation sites |
| US20080107668A1 (en) | 2006-08-30 | 2008-05-08 | Immunotope, Inc. | Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| WO2008031041A2 (en) | 2006-09-07 | 2008-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
| WO2008059252A2 (en) | 2006-11-15 | 2008-05-22 | Oxford Biomedica (Uk) Limited | Methods and composition fro t cell receptors which recognize 5t4 antigen |
| JP5439815B2 (ja) | 2007-10-25 | 2014-03-12 | 東レ株式会社 | 癌の検出方法 |
| JP5663834B2 (ja) | 2008-03-14 | 2015-02-04 | 東ソー株式会社 | 遺伝子組換え抗体の製造方法 |
| EP3269366B1 (en) | 2008-03-18 | 2020-01-15 | Genentech, Inc. | Combinations of an anti-her2 antibody-drug conjugate and lapatinib, and methods of use |
| BR122020027042B1 (pt) | 2008-08-05 | 2022-11-08 | Toray Industries, Inc | Uso de um agente indutor de imunidade, uso de um polipeptídeo e uso de um vetor recombinante |
| WO2010016527A1 (ja) | 2008-08-05 | 2010-02-11 | 東レ株式会社 | 癌の検出方法 |
| CN102170907A (zh) | 2008-08-05 | 2011-08-31 | 东丽株式会社 | 用于治疗和预防癌症的药物组合物 |
| CA2771441C (en) | 2009-08-19 | 2016-10-11 | Merck Patent Gmbh | Antibodies for the detection of integrin complexes in ffpe material |
| MY160680A (en) | 2009-09-22 | 2017-03-15 | Probiogen Ag | Process for producing molecules containing specialized glycan structures |
| RU2418587C1 (ru) * | 2010-01-21 | 2011-05-20 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО "НижГМА Росздрава") | Способ лечения злокачественных опухолей головного мозга |
| RU2607366C2 (ru) | 2010-02-04 | 2017-01-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
| CA2788716C (en) | 2010-02-04 | 2019-06-18 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| ES2691738T3 (es) | 2010-02-04 | 2018-11-28 | Toray Industries, Inc. | Agente farmacéutico para el tratamiento y/o la prevención de cáncer |
| WO2011096519A1 (ja) | 2010-02-04 | 2011-08-11 | 東レ株式会社 | 癌の治療及び／又は予防用医薬組成物 |
| KR101805520B1 (ko) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
| US8911740B2 (en) | 2010-02-04 | 2014-12-16 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
| WO2012005550A2 (ko) | 2010-07-08 | 2012-01-12 | 강원대학교산학협력단 | 담낭암 치료용 약제학적 조성물 및 이를 이용한 담낭암의 성장, 전이 억제 및 치료 방법 |
| CN103261224B (zh) | 2010-07-26 | 2015-10-07 | 瑟维尔实验室 | 用于肝癌治疗的方法和组合物 |
| MX349907B (es) | 2011-08-04 | 2017-08-18 | Toray Industries | Metodo para detectar cancer pancreatico. |
| HUE047006T2 (hu) | 2011-08-04 | 2020-04-28 | Toray Industries | Anti-caprin-1 antitesteket tartalmazó gyógyászati kompozíció rák kezelésére és/vagy megelõzésére |
| RU2630638C2 (ru) | 2011-08-04 | 2017-09-11 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака поджелудочной железы |
| CN104203281B (zh) * | 2012-03-30 | 2019-07-26 | 东丽株式会社 | 胆囊癌的治疗和/或预防用药物组合物 |
| CA2869120C (en) * | 2012-03-30 | 2023-05-23 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of liver cancer |
-
2012
- 2012-08-03 HU HUE17163690A patent/HUE047006T2/hu unknown
- 2012-08-03 JP JP2012543824A patent/JP6070191B2/ja active Active
- 2012-08-03 MX MX2014001375A patent/MX351682B/es active IP Right Grant
- 2012-08-03 ES ES12820596.0T patent/ES2634249T3/es active Active
- 2012-08-03 KR KR1020147005881A patent/KR101979208B1/ko active IP Right Grant
- 2012-08-03 US US14/236,793 patent/US9273128B2/en active Active
- 2012-08-03 DK DK17163690.5T patent/DK3351630T3/da active
- 2012-08-03 EP EP17163690.5A patent/EP3351630B1/en active Active
- 2012-08-03 AU AU2012290957A patent/AU2012290957B2/en active Active
- 2012-08-03 RU RU2014108044A patent/RU2641260C2/ru not_active Application Discontinuation
- 2012-08-03 PT PT171636905T patent/PT3351630T/pt unknown
- 2012-08-03 BR BR112014002608A patent/BR112014002608A2/pt not_active Application Discontinuation
- 2012-08-03 EP EP12820596.0A patent/EP2740796B1/en active Active
- 2012-08-03 DK DK12820596.0T patent/DK2740796T3/en active
- 2012-08-03 PT PT128205960T patent/PT2740796T/pt unknown
- 2012-08-03 HU HUE12820596A patent/HUE033149T2/en unknown
- 2012-08-03 CN CN201280038471.0A patent/CN103717740B/zh active Active
- 2012-08-03 ES ES17163690T patent/ES2763122T3/es active Active
- 2012-08-03 PL PL12820596T patent/PL2740796T3/pl unknown
- 2012-08-03 PL PL17163690T patent/PL3351630T3/pl unknown
- 2012-08-03 CA CA2844042A patent/CA2844042C/en active Active
- 2012-08-03 WO PCT/JP2012/069862 patent/WO2013018894A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| PL3351630T3 (pl) | 2020-05-18 |
| JP6070191B2 (ja) | 2017-02-01 |
| MX2014001375A (es) | 2014-03-21 |
| WO2013018894A1 (ja) | 2013-02-07 |
| EP2740796A4 (en) | 2015-04-22 |
| CN103717740B (zh) | 2015-10-21 |
| DK3351630T3 (da) | 2020-01-02 |
| HUE047006T2 (hu) | 2020-04-28 |
| MX351682B (es) | 2017-10-25 |
| EP3351630B1 (en) | 2019-10-16 |
| EP2740796B1 (en) | 2017-05-17 |
| AU2012290957A1 (en) | 2014-03-20 |
| KR101979208B1 (ko) | 2019-05-16 |
| ES2763122T3 (es) | 2020-05-27 |
| RU2641260C2 (ru) | 2018-01-16 |
| EP2740796A1 (en) | 2014-06-11 |
| ES2634249T3 (es) | 2017-09-27 |
| CN103717740A (zh) | 2014-04-09 |
| DK2740796T3 (en) | 2017-07-24 |
| CA2844042C (en) | 2019-06-18 |
| HUE033149T2 (en) | 2017-11-28 |
| KR20140054185A (ko) | 2014-05-08 |
| CA2844042A1 (en) | 2013-02-07 |
| BR112014002608A2 (pt) | 2018-02-20 |
| PL2740796T3 (pl) | 2017-10-31 |
| US20140186359A1 (en) | 2014-07-03 |
| PT2740796T (pt) | 2017-07-26 |
| RU2014108044A (ru) | 2015-09-10 |
| US9273128B2 (en) | 2016-03-01 |
| JPWO2013018894A1 (ja) | 2015-03-05 |
| AU2012290957B2 (en) | 2017-04-20 |
| EP3351630A1 (en) | 2018-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3351630T3 (pl) | Kompozycja farmaceutyczna zawierająca przeciwciała przeciwko CAPRIN-1 do leczenia nowotworu i/lub zapobiegania nowotworowi | |
| PL2532364T3 (pl) | Kompozycja farmaceutyczna zawierająca przeciwciała anty CAPRIN-1 do leczenia i/lub zapobiegania nowotworowi | |
| PL2532366T3 (pl) | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi | |
| PL2740793T3 (pl) | Kompozycja leku do leczenia i/lub zapobiegania nowotworowi | |
| PL2818483T3 (pl) | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi | |
| PL2532680T3 (pl) | Kompozycja medyczna do leczenia raka i/lub zapobiegania | |
| IL227429A0 (en) | The components and methods of cancer treatment | |
| PL2740795T3 (pl) | Kompozycja lekowa do leczenia nowotworu i/lub zapobiegania nowotworowi | |
| PL2740798T3 (pl) | Kompozycja leku do leczenia i/lub zapobiegania nowotworom | |
| HK1209798A1 (en) | Compositions and methods for treating cancer | |
| IL234989B (en) | Compounds and preparations containing them for the treatment of cancer | |
| PL3020730T3 (pl) | Przeciwciała anty-il1rap i ich zastosowanie do leczenia guzów litych | |
| EP2890720A4 (en) | COMPOSITIONS AND METHODS OF TREATING CANCER | |
| BR112012018947A2 (pt) | composição farmacêutica para tratamento e\ou prevenção do cancêr | |
| PL2672966T3 (pl) | Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania | |
| LT2729151T (lt) | Farmacinė kompozicija, gydymo būdai ir jų panaudojimas | |
| SG10201500124VA (en) | Methods and Compositions for Treating Cancer | |
| HK1202248A1 (en) | Compositions and methods for treating neurodegenerative disease | |
| HK1202246A1 (en) | Compositions and methods for treating neurodegenerative disease | |
| IL229231A0 (en) | Preparations and methods for the treatment of cancer | |
| SG11201400976WA (en) | Methods and pharmaceutical compositions for treating cancer | |
| HK1216854A1 (zh) | 用於治療癌症的組合物和方法 | |
| EP2593111A4 (en) | NEW COMPOUNDS FOR THE TREATMENT OF CANCER AND OTHER DISEASES | |
| HK1188566A1 (zh) | 治療癌症的組合物和方法 | |
| HK1202260A1 (en) | Agent for preventing and or treating veisalgia |